Markéta Šimková

Mrs. Markéta Šimková

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in Environmental Research
Verified
Journal Article
Closed access
LKLucie Kolatorova
Lucie Kolatorova
Jana VitkuJana Vitku
Jana Vitku
RHRichard Hampl
Richard Hampl
KAKarolina Adamcova
Karolina Adamcova
TSTereza Skodova
Tereza Skodova
MDMichaela Duskova
Michaela Duskova

1 November 2017 in Talanta
Verified
Journal Article
Closed access
LKLucie Kolatorova
Lucie Kolatorova
TCTereza Chlupacova
Tereza Chlupacova
Jana VitkuJana Vitku
Jana Vitku
MVMartin Vlk
Martin Vlk
JHJiri Heracek
Jiri Heracek
RHRichard Hampl
Richard Hampl

30 September 2020 in Physiological Research
Verified
Journal Article
Closed access
MŠMarkéta Šimková
Markéta Šimková
JVJ. Vítků
J. Vítků
LKL. Kolátorová
L. Kolátorová
JVJ. Vrbíková
J. Vrbíková
MVM. Vosátková
M. Vosátková
MDM. Dušková
M. Dušková
As environmental and genetic components contribute to the PCOS expression, we compared levels of endocrine disruptors, steroid hormones, cytokines, and metabolic parameters in twenty healthy, nine normal-weight PCOS women, and ten obese PCOS women. Steroid hormones, bisphenols (BPA, BPS, BPF, BPAF) and parabens (methyl-, ethyl-, propyl-, butyl-, benzyl-parabens) were measured by liquid chromatography-tandem mass spectrometry. Differences between the groups were assessed using the Mann-Whitney U test. Spearman correlation coefficients were calculated for the individual parameters relationship. Significantly higher levels of BPA, anti-Müllerain hormone, lutropine, lutropine/folitropine ratio, testosterone, androstenedione, 7β-OH-epiandrosterone, and cytokines (IL-6, VEGF, PDGF-bb), were found in normal-weight PCOS women compared to controls. Between normal-weight and obese PCOS women, there were no differences in hormonal, but in metabolic parameters. Obese PCOS women had significantly higher insulin resistance, fatty-liver index, triglycerides, cytokines (IL-2, IL-13, IFN-γ). In healthy, but not in PCOS, women, there was a positive correlation of BPA with testosterone, SHBG with lutropine, and folitropine, while testosterone negatively correlated with SHBG. In obese women with PCOS, insulin resistance negatively correlated with SHBG and estradiol. No differences were observed in the paraben exposure. Levels of BPA were higher in PCOS women, indicating its role in the etiology. Obesity significantly worsens the symptoms.

20 May 2022 in Journal of Chromatography B
Verified
Journal Article
Closed access
MŠMarkéta Šimková
Markéta Šimková
LKLucie Kolátorová
Lucie Kolátorová
PDPavel Drašar
Pavel Drašar
JVJana Vítků
Jana Vítků

30 September 2020 in Physiological Research
Verified
Journal Article
Closed access
MŠMarkéta Šimková
Markéta Šimková
Antonin TichyAntonin Tichy
Antonin Tichy
MDM. Dušková
M. Dušková
PBP. Bradna
P. Bradna
Dental composite materials often contain monomers with bisphenol A (BPA) structure in their molecules, e.g. bisphenol-A glycidyl dimethacrylate (Bis-GMA). In this study, it was examined whether dental restorative composites could be a low-dose source of BPA or alternative bisphenols, which are known to have endocrine-disrupting effects. Bis-GMA-containing composites Charisma Classic (CC) and Filtek Ultimate Universal Restorative (FU) and “BPA-free” Charisma Diamond (CD) and Admira Fusion (AF) were examined. Specimens (diameter 6 mm, height 2 mm, n=5) were light-cured from one side for 20 s and stored at 37 °C in methanol which was periodically changed over 130 days to determine the kinetics of BPA release. BPA concentrations were measured using a dansyl chloride derivatization method with liquid chromatography – tandem mass spectrometry detection. The amounts of BPA were expressed in nanograms per gram of composite (ng/g). BPA release from Bis-GMA-containing CC and FU was significantly higher compared to “BPA-free” CD and AF. The highest 1-day release was detected with FU (15.4±0.8 ng/g), followed by CC (9.1±1.1 ng/g), AF (2.1±1.3 ng/g), and CD (1.6±0.8 ng/g), and the release gradually decreased over the examined period. Detected values were several orders of magnitude below the tolerable daily intake (4 µg/kg body weight/day). Alternative bisphenols were not detected. BPA was released even from “BPA-free” composites, although in significantly lower amounts than from Bis-GMA-containing composites. Despite incubation in methanol, detected amounts of BPA were substantially lower than current limits suggesting that dental composites should not pose a health risk if adequately polymerized.

23 December 2021 in Polymers
Verified
Journal Article
Open access
PDF file
Antonin TichyAntonin Tichy
Antonin Tichy
MŠMarkéta Šimková
Markéta Šimková
RVRadka Vrbova
Radka Vrbova
ARAdela Roubickova
Adela Roubickova
MDMichaela Duskova
Michaela Duskova
PBPavel Bradna
Pavel Bradna
Bisphenol A (BPA)-based monomers are commonly contained in dental resin-based materials. As BPA is an endocrine disruptor, its long-term release from restorative composites and resin-modified glass ionomers (RM-GICs) under two polymerization conditions was measured in this study. Specimens of two conventional composites containing BPA-based monomers, two “BPA-free” composites, and two RM-GICs were polymerized from one side for 20 s at 1300 mW/cm2 or for 5 s at 3000 mW/cm2. The amounts of BPA released in artificial saliva and methanol after 1, 4, 9, 16, 35, 65, 130, and 260 days were measured using liquid chromatography–tandem mass spectrometry. The highest amounts of BPA were released from conventional composites, followed by RM-GICs, while the least was released from “BPA-free” composites. Amounts of released BPA were significantly higher in methanol and decreased gradually after the first day. Fast polymerization (5 s at 3000 mW/cm2) resulted in a significantly higher release of BPA after 1 day, but the effect of polymerization conditions was not significant overall. In conclusion, fast polymerization increased the initial release of BPA, but the released amounts were significantly lower than the current tolerable daily intake (4 μg/kg body weight/day) even in methanol, representing the worst-case scenario of BPA release.